|
PDIA4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.06146211212399E-12 |
| Normal-vs-Stage2 |
8.539000E-03 |
| Normal-vs-Stage3 |
5.93609994492539E-09 |
| Normal-vs-Stage4 |
9.74350045090944E-10 |
| Stage1-vs-Stage2 |
6.849200E-01 |
| Stage1-vs-Stage3 |
1.497570E-02 |
| Stage1-vs-Stage4 |
1.680500E-03 |
| Stage2-vs-Stage3 |
2.907800E-01 |
| Stage2-vs-Stage4 |
1.124820E-01 |
| Stage3-vs-Stage4 |
4.989200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
2.242900E-03 |
| Normal-vs-Asian |
3.032300E-02 |
| Caucasian-vs-AfricanAmerican |
1.821520E-02 |
| Caucasian-vs-Asian |
3.107000E-01 |
| AfricanAmerican-vs-Asian |
3.228000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62647673107585E-12 |
| Normal-vs-Female |
1.15019105351166E-13 |
| Male-vs-Female |
7.071800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.868300E-02 |
| Normal-vs-Age(41-60Yrs) |
2.92432744686266E-13 |
| Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(81-100Yrs) |
8.043800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.775400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.721000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.720400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.147200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.255800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.200600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.831800E-04 |
| Normal-vs-Grade 2 |
9.76569936028682E-11 |
| Normal-vs-Grade 3 |
1.52766688188422E-13 |
| Normal-vs-Grade 4 |
4.3284000050825E-08 |
| Grade 1-vs-Grade 2 |
7.642000E-01 |
| Grade 1-vs-Grade 3 |
7.181800E-02 |
| Grade 1-vs-Grade 4 |
4.626300E-04 |
| Grade 2-vs-Grade 3 |
1.452190E-02 |
| Grade 2-vs-Grade 4 |
2.379400E-04 |
| Grade 3-vs-Grade 4 |
6.562200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.45929995759775E-09 |
| Normal-vs-ccB subtype |
2.10553796620161E-12 |
| ccA subtype-vs-ccB subtype |
8.12939999983442E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.77315972805081E-15 |
| Normal-vs-N1 |
6.019600E-03 |
| N0-vs-N1 |
9.591600E-02 |
|
|
